Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
Rhea-AI Summary
Surgery Partners (NASDAQ:SGRY) will release Q4 2025 results after market close on Monday, March 2, 2026, followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. ET.
Live dial-in numbers, a webcast via the Investor Relations website, and a replay available through March 17, 2026 (passcode 13758530) were provided for investors and other parties.
Positive
- None.
Negative
- None.
News Market Reaction – SGRY
In the Feb 24 session, SGRY declined 0.71%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 11 | Add-on notes pricing | Negative | -2.7% | Priced $425M of 7.250% senior unsecured notes due 2032. |
| Dec 11 | Debt offering launch | Negative | -2.7% | Announced intent to offer additional $425M 7.250% senior notes. |
| Dec 08 | Partnership venture | Positive | -2.7% | Formed JV with Baylor Scott & White for Texas hospital. |
| Nov 10 | Q3 2025 earnings | Negative | -25.4% | Reported Q3 2025 results and cautious outlook commentary. |
| Oct 24 | Earnings date notice | Neutral | +0.4% | Set Q3 2025 earnings release date and call logistics. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news often saw negative reactions, particularly to Q3 2025 earnings and debt offerings, while a partnership update drew a notable selloff despite its strategic tone.
Over the past few months, Surgery Partners reported Q3 2025 earnings with $821.5M revenue and guidance for $3.275–3.30B full‑year revenue, which was followed by a -25.42% one‑day move. Subsequent add‑on note offerings of $425.0M each also coincided with -2.72% moves. A joint‑venture partnership update on Dec 08, 2025 saw a -2.73% reaction. The prior Q3 earnings date announcement on Oct 24, 2025 produced a modest 0.44% gain, suggesting scheduling releases themselves have had limited impact.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time).
You can join the call as follows:
- Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)
- Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)
- Passcode for the live call and the replay: 13758530
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.
To learn more about Surgery Partners, please visit the company's website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution of material company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company's website and is readily accessible.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.
Contact:
Surgery Partners Investor Relations
(615) 234-8940
IR@surgerypartners.com
